Title: Symbiosis of regulatory affairs and drug development to deliver high quality, safe and effective medicines

Biography:

Ramandeep Kaur is a post graduate in pharmacy and has more than 14 years of experience in Regulatory Affairs in pharmaceutical and biotechnological industry. She is well experienced in regulatory aspects of all phases of drug development, approval and life cycle maintenance. She has dealt with different types of submissions for a vast range of products for global markets. Currently, she is working as a Director in RegWeb Consulting Services Inc., Canada.

Abstract

Regulatory Affairs plays a crucial role in the pharmaceutical and biotechnological industry and is involved in all stages of drug development, drug approval and life cycle maintenance of the product after approval. The Drug Discovery and Development cell in the industry is obligated to follow the strict regulations and guidelines issued by health authorities to develop the safe and effective medicines. Regulatory Affairs acts as an interface between the industry and the health authorities and provides strategic advice to ensure regulatory compliance at all stages. The drug development process is changed drastically from the last 2 decades due to new technological advancement in the science. With this advancement, the role of Regulatory Affairs is also broadened and strengthened. The Drug Discovery/Development and Regulatory Affairs have joined hands in the modern process of drug development for interpretation and application of regulations with a goal to provide high quality, safe and effective medicines to the patients.